Stevens Capital Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Stevens Capital Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-4,179	Closed	-$487K	–	1122
2017 Q1	$487K	Sell	4,179 -147	-3%	-$16.3K	0.02%	584
2016 Q4	$455K	Sell	4,326 -14,781	-77%	-$1.55M	0.02%	600
2016 Q3	$2.11M	Buy	19,107 +3,971	+26%	+$526K	0.09%	277
2016 Q2	$2.2M	Buy	+15,136	New	+$2.15M	0.09%	281
2016 Q1	–	Sell	-6,068	Closed	-$938K	–	1161
2015 Q4	$938K	Buy	+6,068	New	+$886K	0.04%	427
2015 Q3	–	Sell	-7,943	Closed	-$1.14M	–	1264
2015 Q2	$1.14M	Sell	7,943 -1,929	-20%	-$275K	0.04%	393
2015 Q1	$1.39M	Buy	+9,872	New	+$1.52M	0.05%	353

Other funds holding TARO

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Stevens Capital Management's TARO Position: Q2 2017 in Review

Stevens Capital Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2017, closing a stake of 4,179 shares — an estimated $487K sold.

Stevens Capital Management first reported a position in TARO in Q1 2015 and held it in 7 quarters. The position peaked at $2.2M in Q2 2016. 140 funds tracked by Wall St. Rank hold TARO as of Q2 2017.

Stevens Capital Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2017 after selling out during the quarter.
Stevens Capital Management sold 4,179 Taro Pharmaceutical Industries Ltd. shares in Q2 2017, an estimated $487K.
Stevens Capital Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2015 and held it in 7 quarters.
Stevens Capital Management's Taro Pharmaceutical Industries Ltd. position peaked at $2.2M in Q2 2016.
140 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2017.

Based on Stevens Capital Management's 13F filing for Q2 2017, filed 11 Aug 2017.